What Is OHSS and What Causes It After IVF?
Ovarian Hyperstimulation Syndrome (OHSS) is an exaggerated response to fertility injections used during in vitro fertilization (IVF). In some women, stimulated ovaries over-respond. Following the final trigger injection (traditionally hCG), active cells in multiple follicles release high levels of Vascular Endothelial Growth Factor (VEGF).
VEGF makes tiny blood vessels temporarily porous and leaky. Fluid escapes your bloodstream and collects in the abdomen (ascites) and occasionally around the lungs. This creates a clinical paradox: your stomach feels swollen and heavy with fluid, yet your actual bloodstream is dehydrated. As fluid leaks out, remaining blood becomes thicker (hemoconcentration), reducing blood flow to kidneys and raising blood clot risks, which is why clinical care prioritizes vascular rehydration.
Normal Bloating vs. Pathological OHSS: How to Tell the Difference
Almost every woman experiences mild pelvic fullness after egg retrieval as stimulated ovaries heal. Normal recovery peaks within 24 to 48 hours and fades by day 4 to 7. In contrast, pathological OHSS symptoms worsen after day three, characterized by expanding abdominal swelling, nausea, and reduced urination.
| Symptom | Normal Recovery | Mild-to-Moderate OHSS | Severe OHSS (Call Clinic) |
| Onset & Timing | Peaks at 24 to 48 hours; resolves in 4 to 7 days. | Starts day 3 to 5; abdominal swelling lingers. | Rapid daily worsening; abdominal distension expands. |
| Belly & Weight | Mild fullness; weight changes <0.5 kg. | Visible waist expansion; weight rises 0.5 to 1.0 kg. | Tense, drum-like belly; weight rises >1 kg in 24 hours. |
| Pain Level | Dull cramps relieved with paracetamol. | Constant heavy aching across lower abdomen. | Severe, unrelenting pain; cannot find resting posture. |
| Food & Fluid | Normal appetite; comfortably tolerates meals. | Frequent nausea; feeling full after few bites. | Persistent vomiting; cannot keep fluids down >8 hours. |
| Urination | Regular trips; pale yellow urine. | Fewer trips; darker amber urine. | Minimal urine (<500 mL/day); dark tea color. |
| Breathing | Normal, easy breathing in all postures. | Mild breathlessness climbing stairs. | Breathless lying flat (orthopnea); chest tightness. |
When Does OHSS Start and How Long Does It Last? (Early vs. Late OHSS)
OHSS symptoms fall into two distinct timelines depending on the hormone driving them:
1. Early OHSS (Trigger-Driven Phase): Begins 3 to 7 days after trigger injection (1 to 5 days post-retrieval). It is driven by the trigger medication. If no fresh embryo transfer occurs, it clears within 7 to 10 days, resolving completely when your period arrives.
2. Late OHSS (Pregnancy-Driven Phase): Appears 10 or more days after retrieval, around your pregnancy test. It is fueled by natural hCG from an implanting embryo. Because pregnancy hCG rises daily, symptoms can last 2 to 4 weeks until hormones stabilize.
A 2026 Leeds study (Alebrahim et al., Human Fertility) confirmed that severe OHSS can occasionally present as fluid around the right lung (pleural effusion) without massive abdominal distension. Any new breathlessness after IVF warrants prompt clinical review.
OHSS Severity Classification: Mild, Moderate, Severe, and Critical
Following RCOG Green-top Guideline No. 5, clinicians classify OHSS symptoms into four stages to determine safe care:
| Severity Stage | Physical Symptoms | Ultrasound Findings | Blood & Urine Checks | Care Setting |
| Mild OHSS | Mild bloating, pelvic ache, slight nausea. | Ovaries enlarged (<8 cm); minimal pelvic fluid. | Normal blood counts and kidney function. | Home rest and telephone follow-up. |
| Moderate OHSS | Noticeable swelling, persistent ache, nausea/vomiting. | Ovaries 8 to 12 cm; moderate pelvic fluid. | Hematocrit 41% to 45%; normal kidneys. | Outpatient day-care clinic checks. |
| Severe OHSS | Tense belly, orthopnea, dark urine, vomiting. | Ovaries >12 cm; fluid in belly and lungs. | Hematocrit >45%; kidney strain. | Specialized day clinic or hospital care. |
| Critical OHSS | Oliguria/anuria, severe breathing distress, clot alerts. | Tense ascites, significant pleural effusions. | Hematocrit >55%; organ markers elevated. | Intensive inpatient monitoring and drainage. |
Who Is at High Risk for OHSS? (PCOS, High AMH & Antral Follicles)
Developing OHSS symptoms is largely predictable. Certain ovarian and physiological profiles make follicles hypersensitive to gonadotropin stimulation:
– Polycystic Ovary Syndrome (PCOS): Expanded pool of sensitive resting follicles responding vigorously to stimulation.
– High AMH and Antral Follicles: AMH >3.5 ng/mL or AFC >20 follicles indicates high reserve requiring conservative dosing.
– Younger Age and Lean BMI: Women under 35 have denser hormone receptors, while lower body mass concentrates medications.
| Clinical Indicator | Standard Range | High Sensitivity Level | Protective Medical Action |
| Baseline AMH | 1.2 to 3.5 ng/mL | >3.5 ng/mL | Uses modern antagonist protocol with lower starting doses. |
| Antral Follicle Count | 8 to 18 follicles | >20 to 24 follicles | Selects gentle gonadotropin dosing (112.5 to 150 IU daily). |
| Follicles on Trigger Day | <14 follicles | >18 to 20 follicles | Switches to a GnRH agonist trigger (Leuprolide). |
| Peak Estradiol (E2) | <2,500 pg/mL | >3,500 to 4,000 pg/mL | Recommends elective freeze-all embryos to prevent late OHSS. |
| Oocytes Retrieved | 8 to 14 eggs | >18 to 24 eggs | Prescribes a short course of Cabergoline tablets post-retrieval. |
How Modern IVF Prevents OHSS (Agonist Triggers & The Freeze-All Strategy)
Severe OHSS is largely preventable in modern IVF centers thanks to four proven clinical interventions:
– GnRH Antagonist Protocol: Cochrane review (Mourad et al., 2017) shows antagonist protocols reduce OHSS risk by ~50% compared to long agonist protocols, with identical live birth rates.
– GnRH Agonist Trigger (Leuprolide): Replaces hCG with an agonist that clears within 24 hours, causing ovaries to regress rapidly and virtually eliminating early OHSS.
– Freeze-All Embryo Strategy: Sciorio and Esteves (Cryobiology, 2020) demonstrated elective freezing prevents 100% of late OHSS cases. Transferring in a later rested cycle maintains high pregnancy rates.
– Cabergoline Tablets: A 0.5 mg daily oral tablet for 8 days from trigger day blocks VEGF receptors, significantly reducing fluid leakage.
| Strategy | Mechanism of Action | Evidence Base | Clinical Timing |
| Antagonist Protocol | Maintains short, flexible stimulation cycles. | Cochrane Review (Mourad 2017): Cuts OHSS by ~50%. | Started on day 5 to 6 of stimulation. |
| Agonist Trigger | Short LH surge; clears circulation in 24 hours. | Clinical trials: Virtually eliminates early OHSS. | Given 35 to 36 hours pre-retrieval. |
| Freeze-All Embryos | Avoids late pregnancy hCG during stimulated cycle. | Sciorio & Esteves (2020): 100% prevention of late OHSS. | Decided on trigger or retrieval day. |
| Cabergoline | Inactivates VEGF receptors to prevent leakage. | RCOG Guideline 5: Lowers moderate/severe OHSS. | 0.5 mg daily for 8 days from trigger day. |
| Metformin | Improves insulin sensitivity and follicular response. | Cochrane Review: Lowers OHSS in PCOS patients. | Commenced 4 to 8 weeks pre-stimulation. |
Clinical Treatment of OHSS: Outpatient Care, Fluid Balance & Paracentesis
When moderate or severe OHSS symptoms arise, medical care focuses on restoring blood volume, protecting kidney filtration, and preventing blood clots while ovaries recover.
Safe Outpatient Day-Care Management: Gebril, Hamoda, and Mathur (Human Fertility, 2018) confirmed severe OHSS can be safely managed in dedicated outpatient units. Patients receive daily checks, ultrasound fluid tracking, hematocrit tests, and IV albumin infusions to draw fluid into circulation, supported by daily low-dose blood thinners (Enoxaparin) and compression stockings.
Ultrasound-Guided Paracentesis: When accumulated fluid causes severe discomfort, breathlessness, or reduced urine output, specialists perform an outpatient paracentesis. Under ultrasound guidance, a fine catheter drains 1 to 2 liters of fluid, instantly relieving diaphragmatic pressure and restoring normal breathing and kidney filtration.
What Actually Helps at Home for OHSS Symptoms (And What Makes Them Worse)
For mild-to-moderate OHSS managed at home, following evidence-based self-care ensures a smooth recovery:
What Helps:
– Drink fluids with electrolytes, not just plain water: Fluid shifts cause salt loss. Drinking gallons of plain water can cause dilutional hyponatremia. Consume oral rehydration salts (ORS), tender coconut water, and salted broths.
– Take paracetamol for discomfort: Paracetamol (500 to 1,000 mg every 6 to 8 hours, up to 3,000 mg/day) safely relieves pelvic cramps without stressing kidneys.
– Engage in gentle indoor walking: Avoid complete bed rest. Walking around your room for 5 to 10 minutes every few hours prevents sluggish blood pooling in leg veins and lowers clot risks.
– Track daily health metrics: Weigh yourself each morning on the same scale, measure waist circumference, and track urine frequency and color.
What Makes OHSS Worse (Important Warnings):
– NEVER take NSAIDs (Ibuprofen, Combiflam, Brufen): NSAIDs compromise kidney blood flow when blood volume is already low, triggering acute kidney strain. Use paracetamol exclusively.
– DO NOT take diuretics (water pills): Diuretics pull fluid from circulation rather than the abdomen, worsening dehydration and blood clot risks.
– AVOID strenuous exercise and intercourse: Heavy, enlarged ovaries can twist on their blood supply (ovarian torsion), requiring urgent surgery.
Does OHSS Affect Egg Quality, Embryos, or Pregnancy Outcomes?
Patients frequently worry that an exaggerated ovarian response harms their eggs or future children. Medical research provides definitive reassurance:
Egg & Embryo Genetics: OHSS is a maternal vascular condition, not a genetic defect. PGT-A chromosomal testing confirms embryos from hyperstimulated cycles have identical normal chromosome rates compared to standard cycles.
Pregnancy Success: Following elective embryo freezing and transfer in a rested cycle, implantation rates, live birth rates, and infant health are fully preserved.
Future IVF Cycles: Having OHSS once does not dictate future cycles. Using antagonist protocols, lower starting doses, and agonist triggers allows subsequent cycles to proceed with zero recurrence.
Common Patient Myths vs. Clinical Realities About OHSS Symptoms
| Common Patient Myth | Clinical Reality | Medical Science Explanation |
| Myth 1: ‘Drinking gallons of plain water flushes OHSS.’ | Excessive plain water can dangerously dilute blood sodium. | Water leaks into abdomen. Electrolyte fluids (ORS, coconut water) expand blood volume safely. |
| Myth 2: ‘Water pills quickly shrink bloated stomachs.’ | Diuretics dehydrate blood vessels and increase clot risk. | Diuretics pull fluid from circulation, not the abdomen, worsening low blood pressure and kidney strain. |
| Myth 3: ‘Staying in bed all day promotes recovery.’ | Complete bed rest promotes blood clot formation in legs. | Thick blood needs circulation. Gentle walking every few hours protects leg veins. |
| Myth 4: ‘OHSS permanently harms egg quality.’ | OHSS is a vascular condition, not an oocyte defect. | Embryos created in hyperstimulated cycles exhibit completely normal fertilization and genetic health. |
| Myth 5: ‘Freezing embryos lowers overall IVF success.’ | Elective freezing improves pregnancy rates in high responders. | A rested endometrium unexposed to high stimulation hormones is significantly more receptive. |
| Facing Ovarian Hyper-Response or Experiencing Post-Retrieval Bloating? Your comfort and clinical safety are our foremost priorities throughout your IVF journey. At Ferty9 Fertility Center, our senior fertility specialists utilize tailored stimulation protocols, modern agonist triggers, and elective embryo freezing to protect your health while maximizing success.If you are experiencing persistent bloating, nausea, or breathing discomfort after egg retrieval, contact our care team or visit your nearest Ferty9 clinic in Hyderabad, Vijayawada, or Visakhapatnam for evaluation.24/7 Patient Helpline: 1800 296 0000 | Book an Evaluation: https://www.ferty9.com/book-an-appointment |
Frequently Asked Questions About OHSS
What is OHSS and why does it happen after IVF?
Ovarian Hyperstimulation Syndrome (OHSS) is an unintended reaction to IVF stimulation. Stimulated ovaries release VEGF after an hCG trigger injection, making tiny blood vessels leaky. Fluid escapes the bloodstream and pools in the belly and chest, causing abdominal swelling, nausea, and intravascular dehydration.
Is OHSS dangerous or life-threatening?
Most presentations of OHSS symptoms are mild, causing manageable abdominal bloating that resolves within 7 to 10 days. Severe OHSS occurs in only 1% to 2% of cycles and can cause blood clots or kidney strain if unmonitored. Early clinical triage and modern outpatient management prevent severe complications.
How long does bloating usually last after egg retrieval?
Normal bloating peaks 24 to 48 hours after retrieval and subsides over 4 to 7 days. If mild OHSS symptoms develop, bloating can linger for 7 to 10 days until your period begins. If swelling worsens significantly after day three, contact your clinic for an ultrasound.
Can I get OHSS after a frozen embryo transfer (FET)?
No. A frozen embryo transfer does not involve ovarian stimulation or multiple growing follicles, making OHSS physiologically impossible in an FET cycle. Freezing embryos and deferring transfer is the definitive strategy used to eliminate late OHSS.
Is developing OHSS a sign that I am pregnant?
Late OHSS symptoms (swelling starting 10 or more days after retrieval) often coincide with early pregnancy because an implanting embryo produces natural hCG, restimulating the ovaries. However, symptoms alone are not diagnostic; a quantitative beta-hCG blood test is required.
Can you develop OHSS from IUI treatment?
Yes, mild OHSS can occasionally occur during IUI if injectable gonadotropins were used. However, because IUI aims for only 1 to 3 mature follicles rather than the higher numbers in IVF, moderate or severe OHSS is extremely rare (under 1%).
Does OHSS harm egg quality or embryo development?
No. Medical research confirms OHSS affects maternal vascular permeability, not egg or embryo genetics. Eggs from stimulated cycles fertilize normally, and embryos show standard chromosomal normalcy when tested via PGT-A.
Does drinking large amounts of plain water prevent OHSS?
No. Drinking excessive plain water can dangerously dilute blood sodium levels (dilutional hyponatremia). Drink fluids containing balanced electrolytes, such as oral rehydration salts (ORS), tender coconut water, and clear broths, to support circulation safely.
Will I need to be admitted to the hospital for OHSS?
Most patients do not require hospital admission. Mild cases are managed at home, and moderate cases are monitored through daytime outpatient visits. Hospital admission is reserved for severe breathing distress, intractable vomiting, or abnormal blood test results.
Can OHSS be prevented completely during IVF?
While individual biology varies, modern IVF has made severe OHSS largely preventable. By using antagonist protocols, agonist triggers (Leuprolide), elective embryo freezing, and protective Cabergoline tablets, top fertility centers maintain severe OHSS symptoms near zero.
References
All clinical recommendations, diagnostic criteria, and prevention protocols in this guide are verified against peer-reviewed reproductive endocrinology literature and international practice guidelines:
Mourad S, Brown J, Farquhar C. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews. 2017;1(1):CD012103. PMID: 28111738. DOI: 10.1002/14651858.CD012103.pub2. https://pubmed.ncbi.nlm.nih.gov/28111738/
Royal College of Obstetricians and Gynaecologists (RCOG). The Management of Ovarian Hyperstimulation Syndrome. Green-top Guideline No. 5. London: RCOG; Published 2016 (Reaffirmed). https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/the-management-of-ovarian-hyperstimulation-syndrome-green-top-guideline-no-5/
Gebril A, Hamoda H, Mathur R. Outpatient management of severe ovarian hyperstimulation syndrome: a systematic review and a review of existing guidelines. Human Fertility (Cambridge). 2018;21(2):98-105. PMID: 28554223. DOI: 10.1080/14647273.2017.1332752. https://pubmed.ncbi.nlm.nih.gov/28554223/
Sciorio R, Esteves SC. Clinical utility of freeze-all approach in ART treatment: A mini-review. Cryobiology. 2020;92:9-14. PMID: 31770530. DOI: 10.1016/j.cryobiol.2019.11.043. https://pubmed.ncbi.nlm.nih.gov/31770530/
Alebrahim Y, Palinska-Rudzka K, Nancarrow L, Drakeley A, Mathur R. Atypical presentation of severe ovarian hyperstimulation syndrome complicated by isolated pleural effusions: a case series and literature review. Human Fertility (Cambridge). 2026;29(1):2654446. PMID: 41995024. DOI: 10.1080/14647273.2026.2654446. https://pubmed.ncbi.nlm.nih.gov/41995024/
No need to worry, your data is 100% safe with us!